Cite

HARVARD Citation

    Pang, W. et al. (2022). Qingjin Yiqi granules for post‐COVID‐19 condition: A randomized clinical trial. Journal of evidence-based medicine. 15 (1), pp. 30-38. [Online]. 
  
Back to record